News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wechsler Daniel Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/14/2018 |
4
| Wechsler Daniel Mark (See Remarks) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 150,000 options to buy
@ $7.45, valued at
$1.1M
|
|
| 05/31/2018 |
4
| Wechsler Daniel Mark (See Remarks) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Bought 50,000 shares
@ $5, valued at
$250k
|
|
| 11/07/2017 |
4
| Wechsler Daniel Mark (President and CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/|
Txns:
| Granted 550,981 options to buy
@ $11.63, valued at
$6.4M
Granted 183,661 restricted stock units
@ $0 |
|
| 11/07/2017 |
3
| Wechsler Daniel Mark (President and CEO) has filed a Form 3 on MELINTA THERAPEUTICS, INC. /NEW/ |
| 08/14/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/08/2013 |
3
| Wechsler Daniel Mark (EVP, Company Group Chairman) has filed a Form 3 on Valeant Pharmaceuticals International, Inc. |
|
|